Department of Psychiatry, Harvard Medical School, Massachusetts, USA.
National LGBT Health Education Center, The Fenway Institute, Fenway Health, Boston, Massachusetts, USA.
Subst Abus. 2019;40(3):335-339. doi: 10.1080/08897077.2018.1544963. Epub 2019 Feb 13.
Although little is known about the specific burden of the opioid epidemic on lesbian, gay, bisexual, transgender, and queer (LGBTQ) populations, there is evidence to suggest that opioid use disorders are disproportionately prevalent in the LGBTQ community. In this commentary, we present an overview of the current state of evidence on opioid use and misuse among LGBTQ-identified people in the United States and suggest ways to adapt behavioral health interventions to the specific needs of this population. Programs that integrate behavioral health with primary care, address minority stress, and use a trauma-informed approach have the most potential to produce effective, long-term benefits for LGBTQ-identified people with opioid use disorders.
虽然对于阿片类药物流行对女同性恋、男同性恋、双性恋、跨性别和 queer(LGBTQ)人群的具体负担知之甚少,但有证据表明,阿片类药物使用障碍在 LGBTQ 群体中更为普遍。在这篇评论中,我们概述了目前在美国 LGBTQ 人群中阿片类药物使用和滥用的证据现状,并提出了一些方法来使行为健康干预措施适应这一人群的特殊需求。将行为健康与初级保健相结合、解决少数群体压力问题并采用创伤知情方法的项目最有可能为患有阿片类药物使用障碍的 LGBTQ 人群带来有效、长期的益处。